Estrogen Patch Shortage in the U.S. Affects Hormone Therapy Access
The U.S. is experiencing a shortage of estrogen patches, a vital hormone therapy for women in perimenopause and menopause. This shortage has left many women unable to access the medication needed to manage symptoms such as night sweats, hot flashes, and vaginal dryness. The patch delivers medication transdermally, bypassing the liver and potentially reducing side effects like blood clots and strokes. The shortage is primarily driven by increased demand, with prescriptions for hormone replacement therapy rising by 86% since 2021. The FDA's removal of the black box warning has contributed to the growing interest in hormonal options. 
